Results of a program to test women for rectal chlamydia and gonorrhea

Obstetrics and Gynecology

Volumn 115, Issue 4, 2010, Pages 753-759

  Barry, Pennan M ^a   Kent, Charlotte K ^a   Philip, Susan S ^a   Klausner, Jeffrey D ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ANUS INTERCOURSE; ARTICLE; CASE FINDING; CHLAMYDIASIS; CONTROLLED STUDY; FEMALE; GENITAL TRACT INFECTION; GONORRHEA; GYNECOLOGICAL EXAMINATION; HEALTH PROGRAM; HUMAN; MAJOR CLINICAL STUDY; OUTPATIENT DEPARTMENT; PRIORITY JOURNAL; RECTAL TESTING; RECTUM; RECTUM DISEASE; RECTUM INFECTION; RISK FACTOR;

ADOLESCENT; ADULT; AGED; CHLAMYDIA INFECTIONS; FEMALE; GONORRHEA; HUMANS; MIDDLE AGED; NUCLEIC ACID AMPLIFICATION TECHNIQUES; RECTAL DISEASES; RECTUM; SEXUAL BEHAVIOR; SEXUALLY TRANSMITTED DISEASES, BACTERIAL; VAGINAL SMEARS; YOUNG ADULT;

EID: 77949910818     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1097/AOG.0b013e3181d444f6     Document Type: Article

References (31)

1. Centers for Disease Control and Prevention, Sexually transmitted disease surveillance 2008. Atlanta (GA): U.S. Department of Health and Human Services, 2009.
2. Renault CA, Hall C, Kent CK, Klausner JD. Use of NAATs for STD diagnosis of GC and CT in non-FDA-cleared anatomic specimens. MLO Med Lab Obs 2006;38:10-22.
3. Schachter J, Moncada J, Liska S, Shayevich C, Klausner JD. Nucleic acid amplification tests in the diagnosis of chlamydial and gonococcal infections of the oropharynx and rectum in men who have sex with men. Sex Transm Dis 2008;35: 637-642
4. Centers for Disease Control and Prevention, Workowski KA, Berman SM. Sexually transmitted diseases treatment guidelines 2006. MMWR Recomm Rep 2006 55(RR-11) 1-94.
5. Kent CK, Chaw JK, Wong W, Liska S, Gibson S, Hubbard G, et al. Prevalence of rectal, urethral, and pharyngeal chlamydia and gonorrhea detected in 2 clinical settings among men who have sex with men: San Francisco, California, 2003. Clin Infect Dis 2005;41:67-74.
6. Kinghorn GR, Rashid S. Prevalence of rectal and pharyngeal infection in women with gonorrhoea in Sheffield. Br J Vener Dis 1979;55:408-410
7. San Francisco STD Prevention and Control Services. San Francisco sexually transmitted disease monthly report January 2006. San Francisco (CA): San Francisco Department of Public Health 2006.
8. San Francisco STD Prevention and Control Services. San Francisco sexually transmitted disease monthly report September 2005. San Francisco (CA): San Francisco Department of Public Health 2005.
9. Barry PM, Kent CK, Klausner JD. Risk factors for gonorrhea among heterosexuals-San Francisco, 2006. Sex Transm Dis 2009;362:S62-6.
10. Misegades L, Page-Shafer K, Halperin D, McFarland W; YWS Study Investigators Group. Young Women's Survey. Anal intercourse among young low-income women in California: an overlooked risk factor for HIV? AIDS 2001;15:534-535
11. Bolling DR Jr. Prevalence, goals and complications of heterosexual anal intercourse in a gynecologic population. J Reprod Med 1977;19:120-124
12. Friedman SR, Flom PL, Kottiri BJ, Neaigus A, Sandoval M, Curtis R, et al. Prevalence and correlates of anal sex with men among young adult women in an inner city minority neighborhood. AIDS 2001;15:2057-2060
13. Baldwin JI, Baldwin JD. Heterosexual anal intercourse: an understudied, high-risk sexual behavior. Arch Sex Behav 2000;29:357-373
14. Daling JR, Madeleine MM, Johnson LG, Schwartz SM, Shera KA, Wurscher MA, et al. Human papillomavirus, smoking, and sexual practices in the etiology of anal cancer. Cancer 2004;101:270-280
15. Weinberg MS, Lottes IL, Aveline D. AIDS risk reduction strategies among United States and Swedish heterosexual university students. Arch Sex Behav 1998;27:385-401.
16. Tian LH, Peterman TA, Tao G, Brooks LC, Metcalf C, Malotte CK, et al. Heterosexual anal sex activity in the year after an STD clinic visit. Sex Transm Dis 2008;35:905-909
17. Lescano CM, Houck CD, Brown LK, Doherty G, Diclemente RJ, Fernandez MI, et al. Correlates of heterosexual anal intercourse among at-risk adolescents and young adults. Am J Public Health 2009;99:1131-1136
18. Coghill DV, Young H. Genital gonorrhoea in women: a serovar correlation with concomitant rectal infection. J Infect 1989;18:131-141
19. Manavi K, Young H, Clutterbuck D. Sensitivity of microscopy for the rapid diagnosis of gonorrhoea in men and women and the role of gonorrhoea serovars. Int J STD AIDS 2003;14: 390-394
20. Workowski KA, Lampe MF, Wong KG, Watts MB, Stamm WE. Long-term eradication of Chlamydia trachomatis genital infection after antimicrobial therapy. Evidence against persistent infection. JAMA 1993;270:2071-2075
21. Shafer MA, Moncada J, Boyer CB, Betsinger K, Flinn SD, Schachter J. Comparing first-void urine specimens, self-collected vaginal swabs, and endocervical specimens to detect Chlamydia trachomatis and Neisseria gonorrhoeae by a nucleic acid amplification test. J Clin Microbiol 2003;41: 4395-4399
22. Gen-Probe Inc. Package insert: Gen-Probe Aptima Combo 2 Assay (IN0037-04, Rev A). San Diego (CA): Gen-Probe, Inc.; 2004.
23. Cook RL, Hutchison SL, Ostergaard L, Braithwaite RS, Ness RB. Systematic review: noninvasive testing for Chlamydia trachomatis and Neisseria gonorrhoeae. Ann Intern Med 2005;142:914-925
24. Golden MR, Hughes JP, Cles LE, Crouse K, Gudgel K, Hu J, et al. Positive predictive value of Gen-Probe APTIMA Combo 2 testing for Neisseria gonorrhoeae in a population of women with low prevalence of N. gonorrhoeae infection. Clin Infect Dis 2004;39:1387-1390
25. Workowski KA, Stevens CE, Suchland RJ, Holmes KK, Eschenbach DA, Pettinger MB, et al. Clinical manifestations of genital infection due to Chlamydia trachomatis in women: differences related to serovar. Clin Infect Dis 1994;19:756-760
26. Barnes RC, Rompalo AM, Stamm WE. Comparison of Chla-mydia trachomatis serovars causing rectal and cervical infections. J Infect Dis 1987;156:953-958
27. Howell MR, Quinn TC, Brathwaite W, Gaydos CA. Screening women for chlamydia trachomatis in family planning clinics: the cost-effectiveness of DNA amplification assays. Sex Transm Dis 1998;25:108-117
28. Hu D, Hook EW III, Goldie SJ. Screening for Chlamydia trachomatis in women 15 to 29 years of age: a cost-effectiveness analysis. Ann Intern Med 2004;141:501-513
29. Marrazzo JM, Celum CL, Hillis SD, Fine D, DeLisle S, Handsfield HH. Performance and cost-effectiveness of selective screening criteria for Chlamydia trachomatis infection in women: implications for a national Chlamydia control strategy. Sex Transm Dis 1997;24:131-141
30. Moscicki AB, Hills NK, Shiboski S, Darragh TM, Jay N, Powell K, et al. Risk factors for abnormal anal cytology in young heterosexual women. Cancer Epidemiol Biomarkers Prev 8:173-178, 1999.
31. Holly EA, Ralston ML, Darragh TM, Greenblatt RM, Jay N, Palefsky JM. Prevalence and risk factors for anal squamous intraepithelial lesions in women. J Natl Cancer Inst 2001;93: 843-849